NCT06226987View on ClinicalTrials.gov

Molecular Imaging in Fabry Disease of the Heart

RecruitingOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

January 2, 2026

Study Completion Date

January 2, 2026

Conditions
Fabry Disease, Cardiac Variant
Interventions
DIAGNOSTIC_TEST

68Ga-DOTATATE PET/MRI

PET/MRI scanning

Trial Locations (1)

CB2 0QQ

RECRUITING

Cambridge University Hospital NHS Foundation Trust, Cambridge

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Cambridge

OTHER

NCT06226987 - Molecular Imaging in Fabry Disease of the Heart | Biotech Hunter | Biotech Hunter